Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Assaf-Harofeh Medical Center.
Recruitment status was  Recruiting
Information provided by:
Assaf-Harofeh Medical Center Identifier:
First received: December 5, 2010
Last updated: December 6, 2010
Last verified: December 2010

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Longitudenal Study in the Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Resource links provided by NLM:

Further study details as provided by Assaf-Harofeh Medical Center:

Biospecimen Retention:   Samples Without DNA

serum and urine

Estimated Enrollment: 200
Study Start Date: September 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
twin preganacies


Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

women with twin preganacy undergoing nuchal scan in our department


Inclusion Criteria:

  • a women with a vaiable twin pregnany

Exclusion Criteria:

  • women with thrombophilya
  • women terated with anticoagolant
  • women with vascular disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01255202

Contact: Ran Svirsky, MD 972-8-9779000

Assaf Harofe Medical Center Recruiting
Zrifin, Israel
Contact: Ran Svirsky, MD    972-8-9779000   
Principal Investigator: Ran Svirsky, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

No publications provided

Responsible Party: Svirsky Ran, Assaf-Harofeh Medical Center Identifier: NCT01255202     History of Changes
Other Study ID Numbers: 189/09
Study First Received: December 5, 2010
Last Updated: December 6, 2010
Health Authority: Israel: Ethics Commission

Keywords provided by Assaf-Harofeh Medical Center:
kongo red

Additional relevant MeSH terms:
Hypertension, Pregnancy-Induced
Pregnancy Complications processed this record on March 02, 2015